查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1868064

SNP基因分型與分析：全球市佔率與排名、總收入及需求預測（2025-2031年）

SNP Genotyping and Analysis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 87 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球 SNP 基因分型和分析市場規模預計在 2024 年達到 18.73 億美元，預計到 2031 年將達到 54.75 億美元，在預測期（2025-2031 年）內以 16.8% 的複合年成長率成長。

單核苷酸多態性（SNP）是指DNA序列特定位點上發生的單一鹼基對變異。通常存在兩種變異（等位基因），其中一種僅存在於1%至5%的人群中。平均而言，兩個人的DNA序列在超過300萬個位點上有差異。在某些情況下，這種變異會導致次要等位基因增加患或表現出特定疾病或性狀的風險。 SNP基因型鑒定和分析產業分為多個細分領域，包括動態等位基因特異性雜合反應、分子信標和SNP微陣列。

全球SNP基因型鑒定與分析領域的主要企業包括賽默飛世爾科技（Thermo Fisher Scientific）、Illumina、安捷倫科技（Agilent Technologies）、羅氏（Roche）和Bio-Rad。全球前五名廠商佔據超過87%的市場。主要企業主要分佈在歐洲和北美。按產品類型分類，動態等位基因特異性雜合反應）是最大的細分市場，佔超過48%的市場。按應用領域分類，製藥和藥物基因體學是最大的應用領域，佔超過52%的市場。

本報告旨在按地區/國家、類型和應用對全球 SNP基因型鑒定和分析市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名。

本報告以銷售收入為指標，對SNP基因型鑒定和分析市場規模、估算和預測進行了闡述，基準年為2024年，並涵蓋了2020年至2031年的歷史數據和預測數據。報告採用定量和定性分析相結合的方法，幫助讀者制定業務/成長策略、評估市場競爭、分析自身在當前市場中的地位，並就SNP基因型鑒定和分析做出明智的商業決策。

市場區隔

公司

  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • Roche
  • Bio-rad
  • LGC
  • Sequenom
  • Beckman Coulter
  • QIAGEN
  • Fluidigm

按類型分類的細分市場

  • 動態等位基因特異性雜合反應
  • 分子信標
  • SNP微陣列

應用領域

  • 藥理學和藥物基因組學
  • 診斷調查
  • 農業生物技術
  • 育種與畜牧業

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for SNP Genotyping and Analysis was estimated to be worth US$ 1873 million in 2024 and is forecast to a readjusted size of US$ 5475 million by 2031 with a CAGR of 16.8% during the forecast period 2025-2031.

A SNP is a single base pair mutation that occurs at a specific site in the DNA sequence. There are usually two variations, or alleles, with one occurring only in between 1% to 5% of the population. On average, two humans, DNA sequences differ in more than three million positions. In some cases, this variation results in the one minor allele causing or predisposing the individual to have a certain disease or trait. The SNP Genotyping and Analysis industry can be broken down into several segments, Dynamic Allele-Specific Hybridization, Molecular Beacons, SNP Microarrays, etc.

Global key players of SNP genotyping and analysis include Thermo Fisher Scientific, Illumina, Agilent Technologies, Roche, Bio-rad, etc. Global top five manufacturers hold a share over 87%. The key players are mainly located in Europe and North America. In terms of product, dynamic allele-Specific hybridization is the largest segment, with a share over 48%. And in terms of application, the largest application is pharmaceuticals and pharmacogenomics, with a share over 52%.

This report aims to provide a comprehensive presentation of the global market for SNP Genotyping and Analysis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of SNP Genotyping and Analysis by region & country, by Type, and by Application.

The SNP Genotyping and Analysis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SNP Genotyping and Analysis.

Market Segmentation

By Company

  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • Roche
  • Bio-rad
  • LGC
  • Sequenom
  • Beckman Coulter
  • QIAGEN
  • Fluidigm

Segment by Type

  • Dynamic Allele-Specific Hybridization
  • Molecular Beacons
  • SNP Microarrays

Segment by Application

  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Breeding and Animal Livestock

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of SNP Genotyping and Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of SNP Genotyping and Analysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of SNP Genotyping and Analysis in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 SNP Genotyping and Analysis Product Introduction
  • 1.2 Global SNP Genotyping and Analysis Market Size Forecast (2020-2031)
  • 1.3 SNP Genotyping and Analysis Market Trends & Drivers
    • 1.3.1 SNP Genotyping and Analysis Industry Trends
    • 1.3.2 SNP Genotyping and Analysis Market Drivers & Opportunity
    • 1.3.3 SNP Genotyping and Analysis Market Challenges
    • 1.3.4 SNP Genotyping and Analysis Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global SNP Genotyping and Analysis Players Revenue Ranking (2024)
  • 2.2 Global SNP Genotyping and Analysis Revenue by Company (2020-2025)
  • 2.3 Key Companies SNP Genotyping and Analysis Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies SNP Genotyping and Analysis Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of SNP Genotyping and Analysis
  • 2.6 SNP Genotyping and Analysis Market Competitive Analysis
    • 2.6.1 SNP Genotyping and Analysis Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by SNP Genotyping and Analysis Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SNP Genotyping and Analysis as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Dynamic Allele-Specific Hybridization
    • 3.1.2 Molecular Beacons
    • 3.1.3 SNP Microarrays
  • 3.2 Global SNP Genotyping and Analysis Sales Value by Type
    • 3.2.1 Global SNP Genotyping and Analysis Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global SNP Genotyping and Analysis Sales Value, by Type (2020-2031)
    • 3.2.3 Global SNP Genotyping and Analysis Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Pharmaceuticals and Pharmacogenomics
    • 4.1.2 Diagnostic Research
    • 4.1.3 Agricultural Biotechnology
    • 4.1.4 Breeding and Animal Livestock
  • 4.2 Global SNP Genotyping and Analysis Sales Value by Application
    • 4.2.1 Global SNP Genotyping and Analysis Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global SNP Genotyping and Analysis Sales Value, by Application (2020-2031)
    • 4.2.3 Global SNP Genotyping and Analysis Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global SNP Genotyping and Analysis Sales Value by Region
    • 5.1.1 Global SNP Genotyping and Analysis Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global SNP Genotyping and Analysis Sales Value by Region (2020-2025)
    • 5.1.3 Global SNP Genotyping and Analysis Sales Value by Region (2026-2031)
    • 5.1.4 Global SNP Genotyping and Analysis Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America SNP Genotyping and Analysis Sales Value, 2020-2031
    • 5.2.2 North America SNP Genotyping and Analysis Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe SNP Genotyping and Analysis Sales Value, 2020-2031
    • 5.3.2 Europe SNP Genotyping and Analysis Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific SNP Genotyping and Analysis Sales Value, 2020-2031
    • 5.4.2 Asia Pacific SNP Genotyping and Analysis Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America SNP Genotyping and Analysis Sales Value, 2020-2031
    • 5.5.2 South America SNP Genotyping and Analysis Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa SNP Genotyping and Analysis Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa SNP Genotyping and Analysis Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions SNP Genotyping and Analysis Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions SNP Genotyping and Analysis Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States SNP Genotyping and Analysis Sales Value, 2020-2031
    • 6.3.2 United States SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe SNP Genotyping and Analysis Sales Value, 2020-2031
    • 6.4.2 Europe SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China SNP Genotyping and Analysis Sales Value, 2020-2031
    • 6.5.2 China SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan SNP Genotyping and Analysis Sales Value, 2020-2031
    • 6.6.2 Japan SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea SNP Genotyping and Analysis Sales Value, 2020-2031
    • 6.7.2 South Korea SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia SNP Genotyping and Analysis Sales Value, 2020-2031
    • 6.8.2 Southeast Asia SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India SNP Genotyping and Analysis Sales Value, 2020-2031
    • 6.9.2 India SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India SNP Genotyping and Analysis Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Thermo Fisher Scientific
    • 7.1.1 Thermo Fisher Scientific Profile
    • 7.1.2 Thermo Fisher Scientific Main Business
    • 7.1.3 Thermo Fisher Scientific SNP Genotyping and Analysis Products, Services and Solutions
    • 7.1.4 Thermo Fisher Scientific SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Thermo Fisher Scientific Recent Developments
  • 7.2 Illumina
    • 7.2.1 Illumina Profile
    • 7.2.2 Illumina Main Business
    • 7.2.3 Illumina SNP Genotyping and Analysis Products, Services and Solutions
    • 7.2.4 Illumina SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Illumina Recent Developments
  • 7.3 Agilent Technologies
    • 7.3.1 Agilent Technologies Profile
    • 7.3.2 Agilent Technologies Main Business
    • 7.3.3 Agilent Technologies SNP Genotyping and Analysis Products, Services and Solutions
    • 7.3.4 Agilent Technologies SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Agilent Technologies Recent Developments
  • 7.4 Roche
    • 7.4.1 Roche Profile
    • 7.4.2 Roche Main Business
    • 7.4.3 Roche SNP Genotyping and Analysis Products, Services and Solutions
    • 7.4.4 Roche SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Roche Recent Developments
  • 7.5 Bio-rad
    • 7.5.1 Bio-rad Profile
    • 7.5.2 Bio-rad Main Business
    • 7.5.3 Bio-rad SNP Genotyping and Analysis Products, Services and Solutions
    • 7.5.4 Bio-rad SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Bio-rad Recent Developments
  • 7.6 LGC
    • 7.6.1 LGC Profile
    • 7.6.2 LGC Main Business
    • 7.6.3 LGC SNP Genotyping and Analysis Products, Services and Solutions
    • 7.6.4 LGC SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
    • 7.6.5 LGC Recent Developments
  • 7.7 Sequenom
    • 7.7.1 Sequenom Profile
    • 7.7.2 Sequenom Main Business
    • 7.7.3 Sequenom SNP Genotyping and Analysis Products, Services and Solutions
    • 7.7.4 Sequenom SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Sequenom Recent Developments
  • 7.8 Beckman Coulter
    • 7.8.1 Beckman Coulter Profile
    • 7.8.2 Beckman Coulter Main Business
    • 7.8.3 Beckman Coulter SNP Genotyping and Analysis Products, Services and Solutions
    • 7.8.4 Beckman Coulter SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Beckman Coulter Recent Developments
  • 7.9 QIAGEN
    • 7.9.1 QIAGEN Profile
    • 7.9.2 QIAGEN Main Business
    • 7.9.3 QIAGEN SNP Genotyping and Analysis Products, Services and Solutions
    • 7.9.4 QIAGEN SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
    • 7.9.5 QIAGEN Recent Developments
  • 7.10 Fluidigm
    • 7.10.1 Fluidigm Profile
    • 7.10.2 Fluidigm Main Business
    • 7.10.3 Fluidigm SNP Genotyping and Analysis Products, Services and Solutions
    • 7.10.4 Fluidigm SNP Genotyping and Analysis Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Fluidigm Recent Developments

8 Industry Chain Analysis

  • 8.1 SNP Genotyping and Analysis Industrial Chain
  • 8.2 SNP Genotyping and Analysis Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 SNP Genotyping and Analysis Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 SNP Genotyping and Analysis Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. SNP Genotyping and Analysis Market Trends
  • Table 2. SNP Genotyping and Analysis Market Drivers & Opportunity
  • Table 3. SNP Genotyping and Analysis Market Challenges
  • Table 4. SNP Genotyping and Analysis Market Restraints
  • Table 5. Global SNP Genotyping and Analysis Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global SNP Genotyping and Analysis Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies SNP Genotyping and Analysis Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies SNP Genotyping and Analysis Product Type
  • Table 9. Key Companies Time to Begin Mass Production of SNP Genotyping and Analysis
  • Table 10. Global SNP Genotyping and Analysis Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SNP Genotyping and Analysis as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global SNP Genotyping and Analysis Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global SNP Genotyping and Analysis Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global SNP Genotyping and Analysis Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global SNP Genotyping and Analysis Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global SNP Genotyping and Analysis Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global SNP Genotyping and Analysis Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global SNP Genotyping and Analysis Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global SNP Genotyping and Analysis Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global SNP Genotyping and Analysis Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global SNP Genotyping and Analysis Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global SNP Genotyping and Analysis Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global SNP Genotyping and Analysis Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global SNP Genotyping and Analysis Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global SNP Genotyping and Analysis Sales Value by Region (2020-2025) & (%)
  • Table 27. Global SNP Genotyping and Analysis Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions SNP Genotyping and Analysis Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions SNP Genotyping and Analysis Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions SNP Genotyping and Analysis Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Thermo Fisher Scientific Basic Information List
  • Table 32. Thermo Fisher Scientific Description and Business Overview
  • Table 33. Thermo Fisher Scientific SNP Genotyping and Analysis Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in SNP Genotyping and Analysis Business of Thermo Fisher Scientific (2020-2025)
  • Table 35. Thermo Fisher Scientific Recent Developments
  • Table 36. Illumina Basic Information List
  • Table 37. Illumina Description and Business Overview
  • Table 38. Illumina SNP Genotyping and Analysis Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in SNP Genotyping and Analysis Business of Illumina (2020-2025)
  • Table 40. Illumina Recent Developments
  • Table 41. Agilent Technologies Basic Information List
  • Table 42. Agilent Technologies Description and Business Overview
  • Table 43. Agilent Technologies SNP Genotyping and Analysis Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in SNP Genotyping and Analysis Business of Agilent Technologies (2020-2025)
  • Table 45. Agilent Technologies Recent Developments
  • Table 46. Roche Basic Information List
  • Table 47. Roche Description and Business Overview
  • Table 48. Roche SNP Genotyping and Analysis Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in SNP Genotyping and Analysis Business of Roche (2020-2025)
  • Table 50. Roche Recent Developments
  • Table 51. Bio-rad Basic Information List
  • Table 52. Bio-rad Description and Business Overview
  • Table 53. Bio-rad SNP Genotyping and Analysis Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in SNP Genotyping and Analysis Business of Bio-rad (2020-2025)
  • Table 55. Bio-rad Recent Developments
  • Table 56. LGC Basic Information List
  • Table 57. LGC Description and Business Overview
  • Table 58. LGC SNP Genotyping and Analysis Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in SNP Genotyping and Analysis Business of LGC (2020-2025)
  • Table 60. LGC Recent Developments
  • Table 61. Sequenom Basic Information List
  • Table 62. Sequenom Description and Business Overview
  • Table 63. Sequenom SNP Genotyping and Analysis Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in SNP Genotyping and Analysis Business of Sequenom (2020-2025)
  • Table 65. Sequenom Recent Developments
  • Table 66. Beckman Coulter Basic Information List
  • Table 67. Beckman Coulter Description and Business Overview
  • Table 68. Beckman Coulter SNP Genotyping and Analysis Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in SNP Genotyping and Analysis Business of Beckman Coulter (2020-2025)
  • Table 70. Beckman Coulter Recent Developments
  • Table 71. QIAGEN Basic Information List
  • Table 72. QIAGEN Description and Business Overview
  • Table 73. QIAGEN SNP Genotyping and Analysis Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in SNP Genotyping and Analysis Business of QIAGEN (2020-2025)
  • Table 75. QIAGEN Recent Developments
  • Table 76. Fluidigm Basic Information List
  • Table 77. Fluidigm Description and Business Overview
  • Table 78. Fluidigm SNP Genotyping and Analysis Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in SNP Genotyping and Analysis Business of Fluidigm (2020-2025)
  • Table 80. Fluidigm Recent Developments
  • Table 81. Key Raw Materials Lists
  • Table 82. Raw Materials Key Suppliers Lists
  • Table 83. SNP Genotyping and Analysis Downstream Customers
  • Table 84. SNP Genotyping and Analysis Distributors List
  • Table 85. Research Programs/Design for This Report
  • Table 86. Key Data Information from Secondary Sources
  • Table 87. Key Data Information from Primary Sources

List of Figures

  • Figure 1. SNP Genotyping and Analysis Product Picture
  • Figure 2. Global SNP Genotyping and Analysis Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global SNP Genotyping and Analysis Sales Value (2020-2031) & (US$ Million)
  • Figure 4. SNP Genotyping and Analysis Report Years Considered
  • Figure 5. Global SNP Genotyping and Analysis Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by SNP Genotyping and Analysis Revenue in 2024
  • Figure 7. SNP Genotyping and Analysis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Dynamic Allele-Specific Hybridization Picture
  • Figure 9. Molecular Beacons Picture
  • Figure 10. SNP Microarrays Picture
  • Figure 11. Global SNP Genotyping and Analysis Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global SNP Genotyping and Analysis Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Pharmaceuticals and Pharmacogenomics
  • Figure 14. Product Picture of Diagnostic Research
  • Figure 15. Product Picture of Agricultural Biotechnology
  • Figure 16. Product Picture of Breeding and Animal Livestock
  • Figure 17. Global SNP Genotyping and Analysis Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 18. Global SNP Genotyping and Analysis Sales Value Market Share by Application, 2024 & 2031
  • Figure 19. North America SNP Genotyping and Analysis Sales Value (2020-2031) & (US$ Million)
  • Figure 20. North America SNP Genotyping and Analysis Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Europe SNP Genotyping and Analysis Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Europe SNP Genotyping and Analysis Sales Value by Country (%), 2024 VS 2031
  • Figure 23. Asia Pacific SNP Genotyping and Analysis Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. Asia Pacific SNP Genotyping and Analysis Sales Value by Region (%), 2024 VS 2031
  • Figure 25. South America SNP Genotyping and Analysis Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. South America SNP Genotyping and Analysis Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Middle East & Africa SNP Genotyping and Analysis Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Middle East & Africa SNP Genotyping and Analysis Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Key Countries/Regions SNP Genotyping and Analysis Sales Value (%), (2020-2031)
  • Figure 30. United States SNP Genotyping and Analysis Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. United States SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • Figure 32. United States SNP Genotyping and Analysis Sales Value by Application (%), 2024 VS 2031
  • Figure 33. Europe SNP Genotyping and Analysis Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Europe SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • Figure 35. Europe SNP Genotyping and Analysis Sales Value by Application (%), 2024 VS 2031
  • Figure 36. China SNP Genotyping and Analysis Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. China SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • Figure 38. China SNP Genotyping and Analysis Sales Value by Application (%), 2024 VS 2031
  • Figure 39. Japan SNP Genotyping and Analysis Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. Japan SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • Figure 41. Japan SNP Genotyping and Analysis Sales Value by Application (%), 2024 VS 2031
  • Figure 42. South Korea SNP Genotyping and Analysis Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. South Korea SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • Figure 44. South Korea SNP Genotyping and Analysis Sales Value by Application (%), 2024 VS 2031
  • Figure 45. Southeast Asia SNP Genotyping and Analysis Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. Southeast Asia SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • Figure 47. Southeast Asia SNP Genotyping and Analysis Sales Value by Application (%), 2024 VS 2031
  • Figure 48. India SNP Genotyping and Analysis Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. India SNP Genotyping and Analysis Sales Value by Type (%), 2024 VS 2031
  • Figure 50. India SNP Genotyping and Analysis Sales Value by Application (%), 2024 VS 2031
  • Figure 51. SNP Genotyping and Analysis Industrial Chain
  • Figure 52. SNP Genotyping and Analysis Manufacturing Cost Structure
  • Figure 53. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 54. Bottom-up and Top-down Approaches for This Report
  • Figure 55. Data Triangulation
  • Figure 56. Key Executives Interviewed